TEMOZOLOMIDE

NDC 31722-413 · Camber Pharmaceuticals, Inc.

Generic nameTEMOZOLOMIDE

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TEMOZOLOMIDE

Strength100 mg/1

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

31722-413-14 — 14 CAPSULE in 1 BOTTLE (31722-413-14)

31722-413-31 — 5 CAPSULE in 1 BOTTLE (31722-413-31)

FDA lists these products with the same active ingredient.

16571-820 — temozolomide, 16571-821 — temozolomide, 16729-048 — Temozolomide, 16729-049 — Temozolomide, 16729-050 — Temozolomide, 16729-051 — Temozolomide, 16729-129 — Temozolomide, 16729-130 — Temozolomide, 31722-411 — TEMOZOLOMIDE, 31722-412 — TEMOZOLOMIDE, 31722-414 — TEMOZOLOMIDE, 31722-415 — TEMOZOLOMIDE, 31722-416 — TEMOZOLOMIDE, 47335-890 — Temozolomide, 47335-891 — Temozolomide, 47335-892 — Temozolomide, 47335-893 — Temozolomide, 47335-929 — Temozolomide, 47335-930 — Temozolomide, 65162-801 — Temozolomide, +50 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.